Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (3 quarters reported)
$103M in Q4 2025 → $136M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| PP Praxis Precision Medicines I | 10.5% | Unchanged | 42,900 | $14.4M |
| Whitehawk Therapeutics Inc | 7.3% | Unchanged | 2,165,997 | $9.92M |
| Erasca Inc | 6.1% | Added 34% | 455,000 | $8.34M |
| Trevi Therapeutics Inc | 5.7% | Unchanged | 414,000 | $7.72M |
| Sutro Biopharma Inc | 5.5% | Unchanged | 226,575 | $7.52M |
| Tango Therapeutics Inc | 5.3% | Unchanged | 230,264 | $7.2M |
| Mbx Biosciences Inc | 4.9% | Unchanged | 121,524 | $6.71M |
| Protagonist Therapeutics Inc | 4.8% | Unchanged | 53,000 | $6.5M |
| Edgewise Therapeutics Inc | 4.0% | Unchanged | 133,000 | $5.4M |
| Tandem Diabetes Care Inc | 3.3% | New | 301,000 | $4.54M |
| Disc Medicine Inc | 3.1% | Unchanged | 58,250 | $4.26M |
| Savara Inc | 2.7% | Unchanged | 605,280 | $3.73M |
| Arrivent Biopharma Inc | 2.6% | New | 102,000 | $3.54M |
| Insmed Inc | 2.2% | Unchanged | 28,497 | $3.04M |
| Achieve Life Sciences Inc | 2.2% | Unchanged | 462,355 | $3.02M |
| Ideaya Biosciences Inc | 2.2% | Unchanged | 79,700 | $2.97M |
| Ocular Therapeutix Inc | 2.2% | Unchanged | 300,000 | $2.95M |
| Axsome Therapeutics Inc. | 2.2% | Trimmed 67% | 12,000 | $2.94M |
| Design Therapeutics Inc | 2.0% | New | 185,000 | $2.68M |
| UT United Therapeutics Corp Del | 1.9% | Unchanged | 4,750 | $2.57M |
| SR Scholar Rock Hldg Corp | 1.8% | Unchanged | 45,000 | $2.48M |
| Immix Biopharma Inc | 1.7% | Unchanged | 230,423 | $2.38M |
| Viridian Therapeutics Inc | 1.7% | Unchanged | 125,000 | $2.3M |
| Mineralys Therapeutics Inc | 1.7% | New | 84,168 | $2.27M |
| Bright Minds Biosciences Inc | 1.6% | Unchanged | 31,813 | $2.23M |
| Travere Therapeutics Inc | 1.6% | Trimmed 57% | 39,000 | $2.22M |
| Zura Bio Ltd | 1.6% | Unchanged | 373,128 | $2.2M |
| Artiva Biotherapeutics Inc | 1.4% | New | 200,000 | $1.94M |
| Nektar Therapeutics | 1.4% | Unchanged | 26,900 | $1.88M |
| Compass Therapeutics Inc | 1.2% | Added 54% | 771,000 | $1.69M |
| Cabaletta Bio Inc | 1.2% | Unchanged | 505,431 | $1.57M |
| Vera Therapeutics Inc | 1.0% | Unchanged | 32,700 | $1.4M |
| Evolus Inc | 0.8% | New | 150,000 | $1.04M |
| Celcuity Inc | 0.3% | Unchanged | 4,000 | $418K |
| VT Vyne Therapeutics Inc | 0.2% | Unchanged | 500,551 | $326K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 2 quarters.
quarter ended June 30, 2026 · filed August 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Exited | −440,000 | −$23.2M | — |
| Axsome Therapeutics Inc. | Trimmed | −24,200 | −$5.92M | 2.2% |
| Tandem Diabetes Care Inc | New | +301,000 | +$4.54M | 3.3% |
| Revolution Medicines Inc | Exited | −40,200 | −$3.91M | — |
| Arrivent Biopharma Inc | New | +102,000 | +$3.54M | 2.6% |
| Travere Therapeutics Inc | Trimmed | −52,000 | −$2.95M | 1.6% |
| Design Therapeutics Inc | New | +185,000 | +$2.68M | 2.0% |
| Mineralys Therapeutics Inc | New | +84,168 | +$2.27M | 1.7% |
| Erasca Inc | Added | +115,000 | +$2.11M | 6.1% |
| Soleno Therapeutics Inc | Exited | −59,700 | −$2M | — |
Showing the 10 largest of 13 changes.
quarter ended March 31, 2026 · filed May 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Sutro Biopharma Inc | New | +226,575 | +$5.64M | 4.2% |
| Erasca Inc | New | +340,000 | +$5.5M | 4.1% |
| Jazz Pharmaceuticals PLC | Exited | −31,000 | −$5.27M | — |
| Tango Therapeutics Inc | New | +230,264 | +$4.82M | 3.6% |
| Jazz Pharmaceuticals PLC | Exited | −17,500 | −$2.98M | — |
| Ideaya Biosciences Inc | New | +79,700 | +$2.66M | 2.0% |
| Compass Therapeutics Inc | New | +500,000 | +$2.65M | 2.0% |
| Ocular Therapeutix Inc | New | +300,000 | +$2.54M | 1.9% |
| Viridian Therapeutics Inc | New | +125,000 | +$2.45M | 1.8% |
| Bright Minds Biosciences Inc | New | +31,813 | +$2.32M | 1.7% |
Showing the 10 largest of 14 changes.
Loading...
